Appointment booking for Dr. Gildred Colon, MD is currently not available.Dr. Gildred Colon, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Gildred Colon, MD (she/her) is an Endocrinologist in San juan, PR with over 19 years of experience. What is your opinion of Dr. Gildred Colon, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 19 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Gildred Colon, MD has received over $150,270 which includes payments from the following companies:
$78,114.33 from LILLY USA, LLC
$52,415.58 from ELI LILLY EXPORT S.A. PUERTO RICO BRANCH
$12,045.79 from ELI LILLY AND COMPANY
$1,775.02 from AstraZeneca AB
$1,631.00 from E.R. Squibb & Sons, L.L.C.
$1,370.58 from AstraZeneca Pharmaceuticals LP
$741.54 from GlaxoSmithKline, LLC.
$706.79 from sanofi-aventis U.S. LLC
$571.64 from Boehringer Ingelheim Pharmaceuticals, Inc.
$418.13 from Janssen Pharmaceuticals, Inc
$292.51 from Novo Nordisk Inc
$110.00 from Bayer HealthCare Pharmaceuticals Inc.
$77.91 from Merck Sharp & Dohme Corporation
Payments received by Dr. Gildred Colon, MD were from the following categories:
$95,785.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!